foxo4-dri peptide senolytic mouse study 2023 2024

foxo4-dri peptide senolytic mouse study 2023 2024 FOXO4-DRI: Human Trial Status, Cancer Research & Data Peptide targeting senescent cells restores

Name: foxo4-dri peptide senolytic mouse study 2023 2024 FOXO4-DRI: Human Trial Status, Cancer Research & Data Peptide targeting senescent cells restores
Brand: cantondelareina.com.ar
SKU: 85235613412
Price: 25.69 USD
Availability: InStock
Rating: 4.759600000000001 (10 reviews)

Peptide targeting senescent cells restores stamina, fur, and kidney function in old mice FOXO4 DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53 serine 15 phosphorylation Communications Biology FOXO4 peptide targets myofibroblast ameliorates bleomycininduced pulmonary fibrosis in mice through ECMreceptor interaction pathway Han 2022 Journal of Cellular and Molecular Medicine Wiley Online Library Class II senolytics inhibit survival pathways elicited by senescent Download Scientific Diagram

SKU: 85235613412 · From cantondelareina.com.ar

4.8

USD25.69 USD63.69

Pay in 4 interest-free payments of $6.42 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 13 - Aug 18

Description

Description FOXO4-DRI is a synthetic D-retro-inverso peptide designed to selectively disrupt the FOXO4p53 protein-protein interaction

68 weeks

Researchers continue to investigate BPC-157 due to its apparent involvement in multiple biological signaling pathways rather than a single molecular target